LJT: Port & Catheter, Implanted, Subcutaneous, Intravascular
What it covers
A subcutaneous, implanted, intravascular infusion port and catheter is a device that consists of a subcutaneous, implanted reservoir that connects to a long-term intravascular catheter. The device allows for repeated access to the vascular system for the infusion of fluids and medications and the sampling of blood. The device consists of a portal body with a resealable septum and outlet made of metal, plastic, or combination of these materials and a long-term intravascular catheter is either preattached to the port or attached to the port at the time of device placement. The device is available in various profiles and sizes and can be of a single or multiple lumen design.
The identification in 21 CFR 880.5965, subcutaneous, implanted, intravascular infusion port and catheter. FDA gives LJT no definition of its own, so the regulation’s describes it.
FDA flags LJT devices as implants.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K260916 | FLEXI-PORT Power Injectable Implantable Port | Portal Access, Inc. | Jun 17, 2026 | Traditional |
| K252478 | Vaccess CT Low-Profile Power-Injectable Implantable Port; Vaccess CT Power-Injectable Implantable Port; PowerPort duo M.R.I. Implantable Port | Bard Access Systems, Inc. | Sep 5, 2025 | Special |
| K251253 | PowerPort isp Implantable Port; PowerPort Slim Implantable Port; PowerPort M.R.I. Implantable Port; PowerPort M.R.I. isp Implantable Port | Bard Access Systems, Inc. | Jun 18, 2025 | Special |
| K242328 | PowerPort ClearVUE Slim Implantable Ports and PowerPort ClearVUE Slim Implantable Ports | Bard Access Systems, Inc. | Oct 31, 2024 | Special |
| K232737 | PowerPort ClearVUE Slim ECG Enabled Implantable Port; PowerPort ClearVUE isp ECG Enabled Implantable Port; PowerPort isp M.R.I. ECG Enabled Implantable Port; PowerPort Slim ECG Enabled Implantable Port | Bard Peripheral Vascular, Inc. | Dec 8, 2023 | Special |
| K190559 | SmartPort+ Implantable Ports, SmartPort Plastic Implantable Ports | AngioDynamics, Inc. | May 22, 2020 | Traditional |
| K181446 | Bard Power-Injectable Implantable Ports (PowerPorts®) | C.R. Bard, Inc. | Jul 8, 2019 | Traditional |
| K151239 | NMI DUAL PORT II | Navilyst Medical, Inc. | Jun 6, 2016 | Traditional |
| K153359 | BardPort®, SlimPort®, and X-Port® Implanted Ports | C.R. Bard, Inc. | May 20, 2016 | Special |
| K153238 | Dignity Dual Port | Medcomp ( Medical Components) | Mar 15, 2016 | Traditional |
Clearances by year
30 LJT 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 1 | 90 |
| 2025 | 2 | 43 |
| 2024 | 1 | 86 |
| 2023 | 1 | 92 |
| 2020 | 1 | 444 |
| 2019 | 1 | 402 |
| 2016 | 3 | 182 |
| 2015 | 4 | 164 |
| 2014 | 2 | 113 |
| 2013 | 7 | 150 |
| 2012 | 2 | 143 |
| 2011 | 5 | 144 |
Who submits
15 applicants cleared a LJT device since 2011. 97% of the clearances went to applicants in United States, then France (3%). By type: Traditional 60%, Special 33% and Abbreviated 7%.
| Applicant | Clearances since 2011 |
|---|---|
| C.R. Bard, Inc. | 5 |
| Navilyst Medical, Inc. | 4 |
| Bard Access Systems, Inc. | 3 |
| Medcomp ( Medical Components) | 3 |
| Cook Incorporated | 2 |
| Medical Components, Inc. | 2 |
| Norfolk Medical Products, Inc. | 2 |
| Stealth Therapeutics, Incorporated | 2 |
How FDA classifies it
Class II (special controls) Guidance Document: “Guidance on 510(k) Submissions for Implanted Infusion Ports,” FDA October 1990.
From 21 CFR 880.5965. Special controls are the requirements a 510(k) must show it meets.
Standards
21 CFR 880.5965 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent LJT clearances declared.
Ask about LJT
Questions about LJT
What is FDA product code LJT?
Product code LJT, “Port & Catheter, Implanted, Subcutaneous, Intravascular” in FDA's classification database, is a Class II device type under 21 CFR 880.5965 (subcutaneous, implanted, intravascular infusion port and catheter), reviewed by FDA's General Hospital panel. FDA's 510(k) database lists 288 clearances under LJT, 30 of them since 2011.
How many 510(k) clearances are there under LJT?
FDA’s 510(k) database listed 288 clearances under LJT as of Oct 29, 2026, 30 of them decided since 2011; the most recent decision was Jun 17, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a LJT 510(k)?
For the 4 LJT clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 71 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most LJT clearances?
Since 2011: C.R. Bard, Inc. (5), Navilyst Medical, Inc. (4), Bard Access Systems, Inc. (3), Medcomp ( Medical Components) (3) and Cook Incorporated (2). 15 applicants have cleared a LJT device in that time.